New Hope Middle School officially opened its new Kodiak Calming Cove, a sensory room for children with special needs, recently, and "it'll make a big difference for students to have a safe space they can go into," said Belinda Sloan, the school's principal.

Wed, 09/30/2020 - 16:35

Wed, 09/30/2020 - 01:05

This year’s Climate Week NYC has advanced a shift from climate commitments to climate action. What will company climate action look like in this Decisive Decade? Three plausible futures for companies considering their climate strategy.

Tue, 09/29/2020 - 17:00

Custom Collaborative Executive Director Ngozi Okaro joins Common Impact CEO Danielle Holly to discuss nonprofit management during times of crisis, her recent skilled volunteering projects with S&P global, and racism in the fashion industry.

Tue, 09/29/2020 - 11:00

Michelle DiSabato shares with Benevity a step-by-step approach to a more impactful and measurable action plan. Get 8 specific steps, build measures of success, and takeaway key strategies for increased social and business impact.

Tue, 09/29/2020 - 11:50

La Banque Toronto-Dominion a conclu aujourd’hui l’émission d’une obligation durable de trois ans de 500 M$ US arrivant à échéance le 28 septembre 2023.

Tue, 09/29/2020 - 07:05

Maersk Supply Service A/S and Ørsted, the world leader in offshore wind, have formed a partnership to test an innovative charging buoy that can bring green electricity to offshore wind farm service vessels and potentially to a wide range of maritime vessels.

Tue, 09/29/2020 - 11:00

Today, The Toronto-Dominion Bank closed a three-year US$500 million sustainability bond maturing on September 28, 2023. The issue marks TD's inaugural sustainability bond and the first to be issued under the Bank's Sustainable Bonds Framework.

Tue, 09/29/2020 - 07:05

To gain insight, on August 27, 2020, I moderated a panel of leaders in: financial services, retail, manufacturing, infrastructure, technology and telecommunications to talk about leadership during the pandemic and their view of the future.

Wed, 09/30/2020 - 13:00

Johnson & Johnson (NYSE: JNJ) (the Company) recently announced the launch of its large-scale, pivotal, multi-country Phase 3 trial (ENSEMBLE) for its COVID-19 vaccine candidate, JNJ-78436735, being developed by its Janssen Pharmaceutical Companies.

Mon, 09/28/2020 - 16:35